Dihydroartemisinin Market Report

Global Dihydroartemisinin Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 09, 2022
  • PAGES：167
  • REPORT CODE：GMM802716
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Dihydroartemisinin market report explains the definition, types, applications, major countries, and major players of the Dihydroartemisinin market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Shanghai Natural Bio-engineering Co

    • Botanical Extracts EPZ Ltd

    • Guilin Pharmaceutical

    • Guangxi Xiancaotang Pharmaceutical

    • Novanat Bioresource

    • Sanofi

    • KPC Pharmaceuticals

    • Kerui Nanhai Pharmaceutical

    By Type:

    • Pharmaceutical Grade

    • Industrial Grade

    By End-User:

    • Malaria Treatment

    • Scientific Research

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Dihydroartemisinin Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Dihydroartemisinin Outlook to 2028- Original Forecasts

    • 2.2 Dihydroartemisinin Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Dihydroartemisinin Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Dihydroartemisinin Market- Recent Developments

    • 6.1 Dihydroartemisinin Market News and Developments

    • 6.2 Dihydroartemisinin Market Deals Landscape

    7 Dihydroartemisinin Raw Materials and Cost Structure Analysis

    • 7.1 Dihydroartemisinin Key Raw Materials

    • 7.2 Dihydroartemisinin Price Trend of Key Raw Materials

    • 7.3 Dihydroartemisinin Key Suppliers of Raw Materials

    • 7.4 Dihydroartemisinin Market Concentration Rate of Raw Materials

    • 7.5 Dihydroartemisinin Cost Structure Analysis

      • 7.5.1 Dihydroartemisinin Raw Materials Analysis

      • 7.5.2 Dihydroartemisinin Labor Cost Analysis

      • 7.5.3 Dihydroartemisinin Manufacturing Expenses Analysis

    8 Global Dihydroartemisinin Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Dihydroartemisinin Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Dihydroartemisinin Export by Region (Top 10 Countries) (2017-2028)

    9 Global Dihydroartemisinin Market Outlook by Types and Applications to 2022

    • 9.1 Global Dihydroartemisinin Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Pharmaceutical Grade Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Industrial Grade Consumption and Growth Rate (2017-2022)

    • 9.2 Global Dihydroartemisinin Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Malaria Treatment Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Scientific Research Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Dihydroartemisinin Market Analysis and Outlook till 2022

    • 10.1 Global Dihydroartemisinin Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Dihydroartemisinin Consumption (2017-2022)

      • 10.2.2 Canada Dihydroartemisinin Consumption (2017-2022)

      • 10.2.3 Mexico Dihydroartemisinin Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Dihydroartemisinin Consumption (2017-2022)

      • 10.3.2 UK Dihydroartemisinin Consumption (2017-2022)

      • 10.3.3 Spain Dihydroartemisinin Consumption (2017-2022)

      • 10.3.4 Belgium Dihydroartemisinin Consumption (2017-2022)

      • 10.3.5 France Dihydroartemisinin Consumption (2017-2022)

      • 10.3.6 Italy Dihydroartemisinin Consumption (2017-2022)

      • 10.3.7 Denmark Dihydroartemisinin Consumption (2017-2022)

      • 10.3.8 Finland Dihydroartemisinin Consumption (2017-2022)

      • 10.3.9 Norway Dihydroartemisinin Consumption (2017-2022)

      • 10.3.10 Sweden Dihydroartemisinin Consumption (2017-2022)

      • 10.3.11 Poland Dihydroartemisinin Consumption (2017-2022)

      • 10.3.12 Russia Dihydroartemisinin Consumption (2017-2022)

      • 10.3.13 Turkey Dihydroartemisinin Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Dihydroartemisinin Consumption (2017-2022)

      • 10.4.2 Japan Dihydroartemisinin Consumption (2017-2022)

      • 10.4.3 India Dihydroartemisinin Consumption (2017-2022)

      • 10.4.4 South Korea Dihydroartemisinin Consumption (2017-2022)

      • 10.4.5 Pakistan Dihydroartemisinin Consumption (2017-2022)

      • 10.4.6 Bangladesh Dihydroartemisinin Consumption (2017-2022)

      • 10.4.7 Indonesia Dihydroartemisinin Consumption (2017-2022)

      • 10.4.8 Thailand Dihydroartemisinin Consumption (2017-2022)

      • 10.4.9 Singapore Dihydroartemisinin Consumption (2017-2022)

      • 10.4.10 Malaysia Dihydroartemisinin Consumption (2017-2022)

      • 10.4.11 Philippines Dihydroartemisinin Consumption (2017-2022)

      • 10.4.12 Vietnam Dihydroartemisinin Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Dihydroartemisinin Consumption (2017-2022)

      • 10.5.2 Colombia Dihydroartemisinin Consumption (2017-2022)

      • 10.5.3 Chile Dihydroartemisinin Consumption (2017-2022)

      • 10.5.4 Argentina Dihydroartemisinin Consumption (2017-2022)

      • 10.5.5 Venezuela Dihydroartemisinin Consumption (2017-2022)

      • 10.5.6 Peru Dihydroartemisinin Consumption (2017-2022)

      • 10.5.7 Puerto Rico Dihydroartemisinin Consumption (2017-2022)

      • 10.5.8 Ecuador Dihydroartemisinin Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Dihydroartemisinin Consumption (2017-2022)

      • 10.6.2 Kuwait Dihydroartemisinin Consumption (2017-2022)

      • 10.6.3 Oman Dihydroartemisinin Consumption (2017-2022)

      • 10.6.4 Qatar Dihydroartemisinin Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Dihydroartemisinin Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Dihydroartemisinin Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Dihydroartemisinin Consumption (2017-2022)

      • 10.7.2 South Africa Dihydroartemisinin Consumption (2017-2022)

      • 10.7.3 Egypt Dihydroartemisinin Consumption (2017-2022)

      • 10.7.4 Algeria Dihydroartemisinin Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Dihydroartemisinin Consumption (2017-2022)

      • 10.8.2 New Zealand Dihydroartemisinin Consumption (2017-2022)

    11 Global Dihydroartemisinin Competitive Analysis

    • 11.1 Shanghai Natural Bio-engineering Co

      • 11.1.1 Shanghai Natural Bio-engineering Co Company Details

      • 11.1.2 Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Shanghai Natural Bio-engineering Co Dihydroartemisinin Main Business and Markets Served

      • 11.1.4 Shanghai Natural Bio-engineering Co Dihydroartemisinin Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Botanical Extracts EPZ Ltd

      • 11.2.1 Botanical Extracts EPZ Ltd Company Details

      • 11.2.2 Botanical Extracts EPZ Ltd Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Botanical Extracts EPZ Ltd Dihydroartemisinin Main Business and Markets Served

      • 11.2.4 Botanical Extracts EPZ Ltd Dihydroartemisinin Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Guilin Pharmaceutical

      • 11.3.1 Guilin Pharmaceutical Company Details

      • 11.3.2 Guilin Pharmaceutical Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Guilin Pharmaceutical Dihydroartemisinin Main Business and Markets Served

      • 11.3.4 Guilin Pharmaceutical Dihydroartemisinin Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Guangxi Xiancaotang Pharmaceutical

      • 11.4.1 Guangxi Xiancaotang Pharmaceutical Company Details

      • 11.4.2 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Main Business and Markets Served

      • 11.4.4 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Novanat Bioresource

      • 11.5.1 Novanat Bioresource Company Details

      • 11.5.2 Novanat Bioresource Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Novanat Bioresource Dihydroartemisinin Main Business and Markets Served

      • 11.5.4 Novanat Bioresource Dihydroartemisinin Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Sanofi

      • 11.6.1 Sanofi Company Details

      • 11.6.2 Sanofi Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Sanofi Dihydroartemisinin Main Business and Markets Served

      • 11.6.4 Sanofi Dihydroartemisinin Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 KPC Pharmaceuticals

      • 11.7.1 KPC Pharmaceuticals Company Details

      • 11.7.2 KPC Pharmaceuticals Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 KPC Pharmaceuticals Dihydroartemisinin Main Business and Markets Served

      • 11.7.4 KPC Pharmaceuticals Dihydroartemisinin Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Kerui Nanhai Pharmaceutical

      • 11.8.1 Kerui Nanhai Pharmaceutical Company Details

      • 11.8.2 Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Kerui Nanhai Pharmaceutical Dihydroartemisinin Main Business and Markets Served

      • 11.8.4 Kerui Nanhai Pharmaceutical Dihydroartemisinin Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    12 Global Dihydroartemisinin Market Outlook by Types and Applications to 2028

    • 12.1 Global Dihydroartemisinin Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Pharmaceutical Grade Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Industrial Grade Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Dihydroartemisinin Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Malaria Treatment Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Dihydroartemisinin Market Analysis and Outlook to 2028

    • 13.1 Global Dihydroartemisinin Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.2.2 Canada Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Dihydroartemisinin Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.3.2 UK Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.3.3 Spain Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.3.5 France Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.3.6 Italy Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.3.8 Finland Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.3.9 Norway Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.3.11 Poland Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.3.12 Russia Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Dihydroartemisinin Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.4.2 Japan Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.4.3 India Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Dihydroartemisinin Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.5.3 Chile Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.5.6 Peru Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Dihydroartemisinin Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.6.3 Oman Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Dihydroartemisinin Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Dihydroartemisinin Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Dihydroartemisinin Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Dihydroartemisinin Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Dihydroartemisinin

    • Figure of Dihydroartemisinin Picture

    • Table Global Dihydroartemisinin Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Dihydroartemisinin Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Pharmaceutical Grade Consumption and Growth Rate (2017-2022)

    • Figure Global Industrial Grade Consumption and Growth Rate (2017-2022)

    • Figure Global Malaria Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Scientific Research Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Dihydroartemisinin Consumption by Country (2017-2022)

    • Table North America Dihydroartemisinin Consumption by Country (2017-2022)

    • Figure United States Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Canada Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Mexico Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Table Europe Dihydroartemisinin Consumption by Country (2017-2022)

    • Figure Germany Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure UK Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Spain Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Belgium Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure France Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Italy Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Denmark Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Finland Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Norway Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Sweden Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Poland Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Russia Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Turkey Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Table APAC Dihydroartemisinin Consumption by Country (2017-2022)

    • Figure China Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Japan Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure India Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure South Korea Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Thailand Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Singapore Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Philippines Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Table South America Dihydroartemisinin Consumption by Country (2017-2022)

    • Figure Brazil Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Colombia Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Chile Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Argentina Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Peru Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Table GCC Dihydroartemisinin Consumption by Country (2017-2022)

    • Figure Bahrain Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Oman Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Qatar Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Table Africa Dihydroartemisinin Consumption by Country (2017-2022)

    • Figure Nigeria Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure South Africa Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Egypt Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure Algeria Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Table Oceania Dihydroartemisinin Consumption by Country (2017-2022)

    • Figure Australia Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Dihydroartemisinin Consumption and Growth Rate (2017-2022)

    • Table Shanghai Natural Bio-engineering Co Company Details

    • Table Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai Natural Bio-engineering Co Dihydroartemisinin Main Business and Markets Served

    • Table Shanghai Natural Bio-engineering Co Dihydroartemisinin Product Portfolio

    • Table Botanical Extracts EPZ Ltd Company Details

    • Table Botanical Extracts EPZ Ltd Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Botanical Extracts EPZ Ltd Dihydroartemisinin Main Business and Markets Served

    • Table Botanical Extracts EPZ Ltd Dihydroartemisinin Product Portfolio

    • Table Guilin Pharmaceutical Company Details

    • Table Guilin Pharmaceutical Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Guilin Pharmaceutical Dihydroartemisinin Main Business and Markets Served

    • Table Guilin Pharmaceutical Dihydroartemisinin Product Portfolio

    • Table Guangxi Xiancaotang Pharmaceutical Company Details

    • Table Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Main Business and Markets Served

    • Table Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Product Portfolio

    • Table Novanat Bioresource Company Details

    • Table Novanat Bioresource Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novanat Bioresource Dihydroartemisinin Main Business and Markets Served

    • Table Novanat Bioresource Dihydroartemisinin Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Dihydroartemisinin Main Business and Markets Served

    • Table Sanofi Dihydroartemisinin Product Portfolio

    • Table KPC Pharmaceuticals Company Details

    • Table KPC Pharmaceuticals Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

    • Table KPC Pharmaceuticals Dihydroartemisinin Main Business and Markets Served

    • Table KPC Pharmaceuticals Dihydroartemisinin Product Portfolio

    • Table Kerui Nanhai Pharmaceutical Company Details

    • Table Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kerui Nanhai Pharmaceutical Dihydroartemisinin Main Business and Markets Served

    • Table Kerui Nanhai Pharmaceutical Dihydroartemisinin Product Portfolio

    • Figure Global Pharmaceutical Grade Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Industrial Grade Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Malaria Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dihydroartemisinin Consumption Forecast by Country (2022-2028)

    • Table North America Dihydroartemisinin Consumption Forecast by Country (2022-2028)

    • Figure United States Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Dihydroartemisinin Consumption Forecast by Country (2022-2028)

    • Figure Germany Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Dihydroartemisinin Consumption Forecast by Country (2022-2028)

    • Figure China Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Dihydroartemisinin Consumption Forecast by Country (2022-2028)

    • Figure Brazil Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Dihydroartemisinin Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Dihydroartemisinin Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Dihydroartemisinin Consumption Forecast by Country (2022-2028)

    • Figure Australia Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Dihydroartemisinin Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US